Less Ads, More Data, More Tools Register for FREE

License Agreement

23 Apr 2012 07:00

RNS Number : 8004B
Imagination Technologies Group PLC
23 April 2012
 



23 April 2012

 

Imagination Technologies Group plc

 

Imagination licenses its Ensigma UCC IP to Qualcomm

 

Imagination Technologies Group plc (LSE: IMG; "Imagination"), a leader in System-on-Chip Intellectual Property ("SoC IP"), has signed a license agreement with Qualcomm Incorporated (Nasdaq: QCOM), a world leader in 3G and next-generation mobile technologies, for certain IP from Imagination's Ensigma UCC broadcast, communications and connectivity IP family.

 

Under the terms of its licensing arrangements, Imagination receives license fees and royalty revenues.

 

About Imagination Technologies

 

Imagination Technologies Group plc (LSE:IMG) - a global leader in multimedia and communication technologies - creates and licenses market-leading multimedia IP cores for graphics, video, and display processing, multi-threaded embedded processing/DSP cores and multi-standard communications and connectivity processors. These silicon intellectual property (IP) solutions for systems-on-chip (SoC) are complemented by platform level IP and services, a strong array of software tools and drivers and extensive developer and middleware ecosystems. Target markets include mobile phone, handheld multimedia, home consumer entertainment, mobile and low-power computing, and in-car electronics. Its licensees include many of the leading semiconductor and consumer electronics companies. Imagination has corporate headquarters in the United Kingdom, with sales and R&D offices worldwide. See: www.imgtec.com.

 

 

Contact

 

Imagination Technologies Group plc

01923 260 511

Hossein Yassaie, CEO

Richard Smith, CFO

College Hill

020 7457 2020

Adrian Duffield/Kay Larsen

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCMMGZDKGMGZZM

Related Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Back to RNS